Effects of Subcutaneous Hyaluronidase Administration on Psoriatic Plaques

NCT01987609 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

7

Enrollment

OTHER

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: Hylenex
DRUG: Normal Saline

Sponsor

Tissa Hata, MD